Recently, MedCityNews released a report titled "2019 Medical Industry's Five Major Innovation Trends."
The report was written by Sarah Degala, vice president of BIP Capital. BIP Capital is one of the most active and successful venture capital firms in Southeast Asia, serving entrepreneurs, investors and operators to foster an emerging corporate ecosystem. Sarath Degala has 17 years of investment experience, and achieved significant operational and financial performance in all areas of health care. His investment expertise includes health systems strategy, mergers and acquisitions, operational improvements, physician practice management, revenue cycle, ASC operations, case management, integration and turnaround services.
The arterial network compiles the body of the report for you.
Based on this report, we tried to reflect the following questions:
1. As the forefront of science and technology, what is the most important concern of the US medical industry?
2. Through Sarath Degala, we can also glimpse into the areas and technologies that investors are worth investing in.
3. Will these trends turn the wind vane of China's medical industry? Can domestic medical companies adjust their future strategies and layouts based on this?
The following are the five major areas of medical innovation and their trends that will impact the healthcare industry in 2019:
Behavioral health epidemic
It is undeniable that the United States is in the midst of a serious epidemic of opioids. Currently, more than 130 people die every day from opioid-related drug overdose in the United States. According to the report, 80% of heroin users abuse prescription opioids before using heroin.
The United States is still highly concerned about opioids, and this crisis has indeed highlighted the prevalence of behavioral health disorders. The identification and treatment of behavioral health problems has spread from eating disorders, anxiety and depression to suicidal tendencies, but the US health care service system has not been fully established, and it is impossible to quickly and accurately assess patients' patients at all access points providing medical services. Mental health status.
In the United States, the cost of treatment for behavioral health problems continues to rise. Methadone and buprenorphine treatment centers have become increasingly popular in the past few years. The medical expenses for the treatment of prescription opioid abuse alone exceed $28.9 billion annually.
There was an average delay of 8 to 10 years from the first occurrence of mental health symptoms to the beginning of intervention. Before a behavioral problem becomes a real problem, the provider needs to better identify and treat it.
Mandatory behavioral health screening and techniques designed to better manage dosages are expected to increase in medical activities. Finding alternatives to opioids and new processes and technologies that prevent them from being abused will be one of the most important trends of the year.
Precision medicine
Another trend that will have a major impact on drug research and healthcare technology is the rise of precision medicine or pharmacogenomics. This patient care approach has been a huge success in oncology by focusing on the patient's protein interactions and gene composition to achieve better treatment options.
By comparing the patient's tumor DNA to normal cells, the researchers can understand how cancer occurs and find a therapeutic target. By tracking the genetic map of a patient's tumor, doctors can also find out which treatment is most effective for the patient and to do the right medicine.
A new study by Scipher Medicine, a US biotechnology company, found that 65% of patients receiving prescription treatments from the world's top five best-selling drugs did not respond to the therapy. The medical industry needs new ways to reduce excessive spending on prescriptions and drug research, so precision medicine will have an immediate impact.
It is expected that by 2019, precision medicine will become popular outside the field of oncology. This year, a new study was conducted at Northwestern University. The study used precise profiling for rheumatoid arthritis by genetic mapping of joint tissue to determine which drugs are suitable for which patients. Using the patient's own stem cells to study growth replacement tissue provides a new, customized treatment. Researchers with multiple sclerosis can now also identify prognostic biomarkers to track and predict individual disease progression and determine which treatment is best.
It is expected that pharmaceutical companies will invest heavily in precision medicine in the coming year.
Advance medical procedures to the outpatient center
We have seen an increase in the number of patients treated in outpatient surgical facilities over the past four to five years. Patients are receiving the idea of ​​“correct care, the right place, the right time†to help them understand the benefits of receiving treatment in a professional care center in a timely manner, rather than having to be hospitalized. Insurance companies are the first to offer most of these educations through incentives and empowerment requirements that have transferred traditional inpatient procedures to the outpatient setting.
Importantly, outpatient surgery centers (ASCs) and other outpatient centers are becoming more specialized, focusing on better patient care. With the development of minimally invasive vascular surgery in the ASC environment, complex surgery is expected to continue into the field of outpatients.
Some studies have shown that ASCs have more pronounced efficacy and lower infection rates, saving millions of patients every year. Therefore, we expect that there will be innovations in 2019 that meet the needs of these more specialized centers.
Healthcare network security
FortiGuard Labs reports that in the past year, medical industry organizations have experienced an average of 32,000 network intrusions per day, compared to an average of 14,300 in other industry organizations. In terms of the development of cybersecurity standards, medical institutions still lag far behind the financial and retail industries. Moreover, while data provided by financial services institutions or retailers is more useful to cybercriminals, the value of stolen health data may actually be 10 to 20 times higher than the value of credit card information on the black market.
It is expected that medical institutions will take major initiatives in 2019 to narrow the gap between medical network security standards and other industry standards. However, in terms of network vulnerabilities, this year may be the worst year in the history of the medical industry. In the past year, data breaches have increased every quarter, with 4.39 million medical records being exposed in the third quarter alone. While healthcare industry investors are constantly investing in new healthcare security measures, cybercriminals are constantly demonstrating more sophisticated intrusions.
Machine learning and artificial intelligence healthcare
Another trend affecting the medical industry is the growing popularity of artificial intelligence research and applications. In the past year, the number of medical artificial intelligence start-ups and equity financing has grown steadily, reaching a record high in the previous quarter, making the medical industry the most intensive industry for artificial intelligence trading.
Robotic process automation, manual task automation and deep learning innovation have opened the market for powerful applications in the medical industry. Google's DeepMind is planning to launch a clinical trial in 2019 to try a product that can diagnose eye diseases through artificial intelligence. Apple also invested in the ResearchKit and CareKit software frameworks, which will use machine learning to provide medical researchers with more reliable and meaningful data. BeyondVerbal is another artificial intelligence startup that is studying the voice model and wants to diagnose chronic diseases by phone.
Hundreds of promising new medical artificial intelligence projects are currently being launched. There is no doubt that there will be hundreds in 2019. Especially for pharmaceutical companies, they will drive this trend by investing in artificial intelligence technology in advance. It is expected that there will be several major acquisitions in the field of artificial intelligence and machine learning in 2019, which will reshape the entire industry.
Although we believe these trends are important in 2019, they are actually just the tip of the iceberg. Healthcare professionals and investors must pay close attention to these trends and other trends as they will evolve over the coming year and beyond, with varying degrees of impact on the healthcare industry. As the healthcare industry continues to reform to improve patient care, investors must understand how to adjust their investment strategies accordingly.
Male Sexual Enhancement Material
Male Sexual Enhancement ;Strengthening Yang extract
Shaanxi Zhongyi Kangjian Biotechnology Co.,Ltd , https://www.zhongyibiology.com